Cargando…

Sleep quality in COVID-19 recovered patients

OBJECTIVE: Novel coronavirus disease 2019 is known to have poor impacts on health with health systems facing serious challenges. Limited information is available on health issues for patients who have recovered from the disease. Our study aims to investigate the extent of sleep disorders in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Ameri, Laith Thamer, Hameed, Ekhlas Khalid, Maroof, Bilal S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Brazilian Association of Sleep and Latin American Federation of Sleep 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210556/
https://www.ncbi.nlm.nih.gov/pubmed/35755910
http://dx.doi.org/10.5935/1984-0063.20220037
_version_ 1784730182221824000
author Al-Ameri, Laith Thamer
Hameed, Ekhlas Khalid
Maroof, Bilal S.
author_facet Al-Ameri, Laith Thamer
Hameed, Ekhlas Khalid
Maroof, Bilal S.
author_sort Al-Ameri, Laith Thamer
collection PubMed
description OBJECTIVE: Novel coronavirus disease 2019 is known to have poor impacts on health with health systems facing serious challenges. Limited information is available on health issues for patients who have recovered from the disease. Our study aims to investigate the extent of sleep disorders in patients who have recovered from the coronavirus disease. MATERIAL AND METHODS: A casecontrol study with 256 patients who had recovered from coronavirus disease 2019 was carried out, with 491 patients enrolled as the control. All participants were 18 years or older, and sleep quality was assessed using the Pittsburgh sleep quality index. Furthermore, sleep latency and hours needed for sleep were calculated. Chi-square and t-test statistical methods were used to analyze the variables. RESULTS: A total of 215 (84%) recovered patients were associated with poor sleep quality, with 384 patients (78%) in the control group. The PSQI values for recovered and control groups were 8.77±3.7591 and 8.139±3.068, respectively, with a significant p-value of 0.014. Average hours needed for sleep were 6.899±3.7869 and 6.44±1.477 for recovered and control patients, respectively, with a significant p-value of 0.01. The difference in sleep latency was non-significant (p=0.374), with 29.01±39.3702 and 33.520±38.208 minutes for recovered and control patients, respectively. CONCLUSION: Sleep disorders were more prevalent among patients who had recovered from COVID-19 than the control group.
format Online
Article
Text
id pubmed-9210556
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Brazilian Association of Sleep and Latin American Federation of Sleep
record_format MEDLINE/PubMed
spelling pubmed-92105562022-06-23 Sleep quality in COVID-19 recovered patients Al-Ameri, Laith Thamer Hameed, Ekhlas Khalid Maroof, Bilal S. Sleep Sci Original Articles OBJECTIVE: Novel coronavirus disease 2019 is known to have poor impacts on health with health systems facing serious challenges. Limited information is available on health issues for patients who have recovered from the disease. Our study aims to investigate the extent of sleep disorders in patients who have recovered from the coronavirus disease. MATERIAL AND METHODS: A casecontrol study with 256 patients who had recovered from coronavirus disease 2019 was carried out, with 491 patients enrolled as the control. All participants were 18 years or older, and sleep quality was assessed using the Pittsburgh sleep quality index. Furthermore, sleep latency and hours needed for sleep were calculated. Chi-square and t-test statistical methods were used to analyze the variables. RESULTS: A total of 215 (84%) recovered patients were associated with poor sleep quality, with 384 patients (78%) in the control group. The PSQI values for recovered and control groups were 8.77±3.7591 and 8.139±3.068, respectively, with a significant p-value of 0.014. Average hours needed for sleep were 6.899±3.7869 and 6.44±1.477 for recovered and control patients, respectively, with a significant p-value of 0.01. The difference in sleep latency was non-significant (p=0.374), with 29.01±39.3702 and 33.520±38.208 minutes for recovered and control patients, respectively. CONCLUSION: Sleep disorders were more prevalent among patients who had recovered from COVID-19 than the control group. Brazilian Association of Sleep and Latin American Federation of Sleep 2022 /pmc/articles/PMC9210556/ /pubmed/35755910 http://dx.doi.org/10.5935/1984-0063.20220037 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Al-Ameri, Laith Thamer
Hameed, Ekhlas Khalid
Maroof, Bilal S.
Sleep quality in COVID-19 recovered patients
title Sleep quality in COVID-19 recovered patients
title_full Sleep quality in COVID-19 recovered patients
title_fullStr Sleep quality in COVID-19 recovered patients
title_full_unstemmed Sleep quality in COVID-19 recovered patients
title_short Sleep quality in COVID-19 recovered patients
title_sort sleep quality in covid-19 recovered patients
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210556/
https://www.ncbi.nlm.nih.gov/pubmed/35755910
http://dx.doi.org/10.5935/1984-0063.20220037
work_keys_str_mv AT alamerilaiththamer sleepqualityincovid19recoveredpatients
AT hameedekhlaskhalid sleepqualityincovid19recoveredpatients
AT maroofbilals sleepqualityincovid19recoveredpatients